Evidence map›Paper›PMID 32545345›Full record

ArticleMolecules (Basel, Switzerland)2020

Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers.

Florian Gauthier, Jean-Rémi Bertrand, Jean-Jacques Vasseur, Christelle Dupouy, Françoise Debart

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Florian GauthierIBMM, University of Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Jean-Rémi BertrandMETSY UMR 9018 CNRS, Université Paris-Sud, Gustave Roussy, University Paris-Saclay, 94800 Villejuif Cedex, France.
Jean-Jacques VasseurIBMM, University of Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Christelle DupouyIBMM, University of Montpellier, CNRS, ENSCM, 34095 Montpellier, France.ORCID 0000-0002-4508-838X
Françoise DebartIBMM, University of Montpellier, CNRS, ENSCM, 34095 Montpellier, France.ORCID 0000-0003-3422-3926
École Nationale Supérieure de Chimie de Montpellier · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Co-delivery systems of siRNA and chemotherapeutic drugs have been developed as an attractive strategy to optimize the efficacy of chemotherapy towards cancer cells with multidrug resistance. In these typical systems, siRNAs are usually associated to drugs within a carrier but without covalent interactions with the risk of a premature release and degradation of the drugs inside the cells. To address this issue, we propose a covalent approach to co-deliver a siRNA-drug conjugate with a redox-responsive self-immolative linker prone to intracellular glutathione-mediated disulfide cleavage. Herein, we report the use of two disulfide bonds connected by a pentane spacer or a

Indexed as

DisulfidesDoxorubicinDrug StabilityGlutathioneHumansMolecular StructureRNA, Small InterferingSerumDisulfidesDoxorubicinGlutathioneRNA, Small Interferingconjugationdisulfide bonddoxorubicinself-immolative linkersiRNAthiol-disulfide exchange

Identifiers

PMID32545345
PMCPMC7321315
OpenAlexW3034364930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.